SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living with Type 2 Diabetes Across the Therapeutic Spectrum
CLINICAL THERAPEUTICS（2024）
Key words
Extraglycemic effects,GLP-1Ra,Gout,Insulin,Metformin,SGLT2i
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined